Developer docs
API playgroundTry for free, no card

Search company profiles

I-MED Network Radiology

Full company profile

uuid0009b5o

Namestring
I-MED Network Radiology
Legal namestring
I-MED Radiology Network
Websiteurl
i-med.com.au
Company typeenum
Private
Founded yearint
2000
Descriptiontext

I-MED Radiology Network is Australia's largest diagnostic imaging provider, operating 215+ clinics across all states and territories plus New Zealand, and performing more than 7 million procedures annually. Its service portfolio spans MRI, CT, X-ray, ultrasound, nuclear medicine, PET, mammography, bone densitometry, image-guided biopsy, and interventional procedures, delivered through both consumer-facing clinics and outsourced contracts with leading Australian hospitals. The company also operates the I-TeleRAD teleradiology brand for remote reporting and entered the US market in 2024 via the StatRad acquisition. Underlying technology is a multi-modality imaging stack augmented by third-party clinical software: Volpara Health AI for breast density measurement, Qaelum DOSE for radiation dose monitoring across 208 CT/PET/SPECT systems, 3D breast tomosynthesis, and a Harrison.ai minority stake providing AI capable of analyzing chest X-rays and CT scans across 455 diagnoses. Patient-facing infrastructure includes an online booking platform, the My I-MED portal for image access and appointment management, and an e-referral system for practitioners.

I-MED generates revenue primarily through fee-for-service diagnostic imaging, with a mixed-billing model combining Medicare rebates (processed by clinics on patients' behalf) and provider gap fees. Pensioners and healthcare card holders are bulk-billed for most Medicare-eligible procedures, and participation in the National Lung Cancer Screening Program (effective July 2025) adds a fully government-funded screening volume. A secondary revenue stream comes from managed-service hospital outsourcing contracts for complex cardiac and diagnostic imaging. Customers are segmented across individual patients (referred by GPs and specialists), referring healthcare practitioners, and public/private hospitals. Distribution runs through owned clinics, hospital B2B contracts, the digital self-service platform, and the teleradiology channel.

Ownership transitioned from Permira (2018-2026) to Hong Kong-based conglomerate Jardine Matheson in May 2026 in a deal valued at A$3.4 billion (US$2.4 billion), approximately 11.5x forecasted adjusted EBITDA and one of the first major transactions under Jardine's new CEO Lincoln Pan. Under Permira, the network expanded roughly threefold from ~70 to 215+ clinics. Leadership includes CEO Steven Rubic, CFO Clare Battellino, Head of Sales and Marketing Luke Targett, GM Operations Bruce Potts, and Chief Medical Officer Dr Ronald Shnier.

Short descriptiontext

I-MED Radiology Network is Australia's largest diagnostic imaging provider, operating 215+ clinics across Australia, New Zealand, and the US, performing 7 million+ MRI, CT, X-ray, ultrasound, and PET procedures annually for patients, GPs, specialists, and hospitals under a Medicare mixed-billing and hospital outsourcing model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersSydney, Australia
HQ citystring
Sydney
HQ countrystring
Australia
HQ regionstring
Oceania
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic imaging services, medical imaging network, radiology clinics, teleradiology services, hospital outsourcing
Industry5 codes
1Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound)
CodeHLAFAKAAPrimaryYes
2Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology)
CodeHLAFAKABPrimaryNo
3Nuclear Medicine & Molecular Imaging (SPECT/PET)
CodeHLAHABAEPrimaryNo
4Women’s Imaging & Breast Health Centers
CodeHLAFAJAJPrimaryNo
5Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web)
CodeHLACALAIPrimaryNo
NAICS code2 codes
  • Diagnostic Imaging Centers621512
  • Ambulatory Health Care Services621
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
Product category
Diagnostic Imaging Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Diagnostic Imaging Services
TypeTransaction Fee
Description

Fee-for-service medical imaging procedures where patients pay for radiology services. The company uses a mixed-billing policy combining Medicare rebates (processed by clinic on patient's behalf) plus provider gap fees. Services are provided across MRI, CT, X-ray, ultrasound, nuclear medicine, PET, mammography and interventional procedures.

i-med.com.au
2Hospital Outsourcing Contracts
TypeManaged Services
Description

I-MED serves as trusted outsourced provider to some of Australia's leading hospitals, delivering complex cardiac and diagnostic imaging services

radiologybusiness.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details2 tiers
1Standard radiology procedures with Medicare rebate
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Fees vary by procedure type, Medicare item code, clinical reason, and patient age. Out-of-pocket gap fees apply for most services. Pensioners and healthcare card holders bulk billed for most Medicare-eligible procedures.

i-med.com.au
2National Lung Cancer Screening Program (NLCSP)
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Bulk-billed low-dose CT scans for eligible patients (aged 50-70, 30+ pack-year smoking history). No cost to eligible patients under government screening program.

i-med.com.au
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1I-TeleRAD
Description

Teleradiology services offered by I-MED for remote radiology reporting and image analysis.

i-med.com.au
+1 more record
Core offering1 text field

I-MED Radiology Network operates Australia's largest diagnostic imaging network with 215+ clinics across Australia and New Zealand, providing MRI, CT, X-ray, ultrasound, nuclear medicine, PET scans, mammography, and interventional radiology procedures. Services are delivered to patients referred by GPs and specialists and through outsourced diagnostic imaging contracts with leading Australian hospitals.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

I-MED Radiology Network operates as Australia and New Zealand's largest diagnostic imaging network, offering a comprehensive range of medical imaging services across multiple modalities. The core offering is the I-MED clinic network providing MRI, CT, X-ray, ultrasound, nuclear medicine, PET scans, mammography, and interventional procedures. The network is complemented by patient-facing services including the My I-MED portal for appointment management and image access, and I-TeleRAD for teleradiology services. The organization has also integrated third-party clinical support technologies including Volpara Health's AI-based breast density measurement software and Qaelum DOSE radiation monitoring across its imaging systems.

Product and service6 records
1I-MED Radiology Network Diagnostic Imaging Services
CategoryDiagnostic Imaging
Description

Comprehensive diagnostic imaging services across multiple modalities (MRI, CT, X-ray, ultrasound, nuclear medicine, PET scans, mammography, interventional procedures) provided through a network of 215+ clinics in Australia and New Zealand to patients referred by GPs and specialists.

2Breast Tomosynthesis (3D Mammography)
CategoryDiagnostic Imaging
Description

Advanced 3D mammography service available at select I-MED clinics that improves invasive breast cancer detection by 40% versus traditional mammography, using Volpara Health AI-based breast density measurement software to tailor examinations.

3Cardiac Imaging Services
CategoryDiagnostic Imaging
Description

Specialized cardiac imaging services delivered by 154+ accredited cardiac imaging radiologists, serving both hospital outsourcing clients and direct patient referrals.

4National Lung Cancer Screening Program (NLCSP)
CategoryDiagnostic Imaging
Description

Government-funded lung cancer screening service providing bulk-billed low-dose CT scans at no cost to eligible patients (aged 50-70 with 30+ pack-year smoking history) under the National Lung Cancer Screening Program effective from 1 July 2025.

5I-TeleRAD Teleradiology Services
CategoryTeleradiology
Description

Remote radiology reporting and image interpretation service offered under the I-TeleRAD brand, enabling diagnostic image analysis to be performed remotely for hospitals and healthcare facilities.

6Hospital Outsourcing Services
CategoryDiagnostic Imaging
Description

Outsourced radiology services delivered to leading Australian hospitals, including complex cardiac imaging and diagnostic procedures, serving public and private hospitals requiring supplementary radiology capacity and sub-specialist expertise.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-05-25
Description

I-MED holds a minority stake in Australian AI firm Harrison.ai, which develops radiology AI solutions including software capable of analyzing chest X-rays and CT scans across 455 diagnoses. Harrison.ai's technology is used by 3,400 clinicians across 1,000+ hospitals in more than 40 countries, providing I-MED with access to AI-powered diagnostic capabilities.

Strategic tierMinorTypeOthersAnnounced on2025-09-25
Description

Radiologists bought back control of Jones Radiology by acquiring the 49% stake previously held by I-Med Radiology Network. Jones Radiology had been part of I-Med for over 25 years before the buyback.

Strategic tierMinorTypeOthersAnnounced on2025-01-01
Description

Radiology Partners, America's largest radiology group, reportedly explored a bid to acquire I-MED from Permira, demonstrating market interest in I-MED's assets, though no transaction occurred.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

I-MED expanded into the US market through the 2024 acquisition of StatRad, a US-based radiology company. This represents I-MED's strategic entry into the American diagnostic imaging market.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

America's largest radiology group with a similar hospital-outsourcing and multi-site imaging model. Comparable in scale, multi-modality offering, and PE-backed growth playbook; explored acquiring I-MED from Permira in 2025, demonstrating direct strategic comparability.

TypeDirect peer
Description

ASX-listed radiology operator across Australia and New Zealand. Most direct geographic and operating-model peer to I-MED's ANZ clinic network, competing in many of the same metropolitan and regional markets.

TypeOthers
Description

NZ-based AI breast density software provider whose product is integrated into I-MED's mammography workflow. Adjacent technology supplier rather than direct competitor, but an important ecosystem participant for I-MED's women's imaging offering.

TypeBroad incumbent
Description

ASX-listed diagnostics powerhouse providing pathology and radiology across Australia and globally. Overlaps with I-MED in Australian diagnostic imaging and shares a multi-modality, hospital-referral-driven business model.

TypeBroad incumbent
Description

Large US physician and radiology services group. Broader healthcare services incumbent with overlapping radiology outsourcing but a much wider portfolio than I-MED's imaging-only focus.

TypeOthers
Description

Australian AI company in which I-MED holds a minority stake. Comparable as a partner/investee rather than competitor — its radiology AI capabilities are deployed across I-MED's network.

TypeDirect peer
Description

Private Australian radiology provider with a clinic network across multiple states. Directly comparable to I-MED in service mix, sub-specialist model, and hospital outsourcing contracts.

TypeDirect peer
Description

Australian diagnostics operator (formerly Primary Health Care) running imaging and pathology assets. Directly comparable as a multi-site Australian imaging competitor with similar GP/specialist referral dynamics.

TypeDirect peer
Description

Australian diagnostic imaging group operating community-based clinics. Comparable mid-scale ANZ radiology competitor with overlapping modalities and referral channels.

TypeRegional player
Description

US-focused outpatient imaging and radiology services platform. Comparable in multi-site fixed-site imaging model but geographically distinct from I-MED's ANZ core footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

I-MED Network Radiology

Diagnostic Imaging Servicesi-med.com.au

I-MED Radiology Network is Australia's largest diagnostic imaging provider, operating 215+ clinics across Australia, New Zealand, and the US, performing 7 million+ MRI, CT, X-ray, ultrasound, and PET procedures annually for patients, GPs, specialists, and hospitals under a Medicare mixed-billing and hospital outsourcing model.

What I-MED Network Radiology does

I-MED Radiology Network is Australia's largest diagnostic imaging provider, operating 215+ clinics across all states and territories plus New Zealand, and performing more than 7 million procedures annually. Its service portfolio spans MRI, CT, X-ray, ultrasound, nuclear medicine, PET, mammography, bone densitometry, image-guided biopsy, and interventional procedures, delivered through both consumer-facing clinics and outsourced contracts with leading Australian hospitals. The company also operates the I-TeleRAD teleradiology brand for remote reporting and entered the US market in 2024 via the StatRad acquisition. Underlying technology is a multi-modality imaging stack augmented by third-party clinical software: Volpara Health AI for breast density measurement, Qaelum DOSE for radiation dose monitoring across 208 CT/PET/SPECT systems, 3D breast tomosynthesis, and a Harrison.ai minority stake providing AI capable of analyzing chest X-rays and CT scans across 455 diagnoses. Patient-facing infrastructure includes an online booking platform, the My I-MED portal for image access and appointment management, and an e-referral system for practitioners.

I-MED generates revenue primarily through fee-for-service diagnostic imaging, with a mixed-billing model combining Medicare rebates (processed by clinics on patients' behalf) and provider gap fees. Pensioners and healthcare card holders are bulk-billed for most Medicare-eligible procedures, and participation in the National Lung Cancer Screening Program (effective July 2025) adds a fully government-funded screening volume. A secondary revenue stream comes from managed-service hospital outsourcing contracts for complex cardiac and diagnostic imaging. Customers are segmented across individual patients (referred by GPs and specialists), referring healthcare practitioners, and public/private hospitals. Distribution runs through owned clinics, hospital B2B contracts, the digital self-service platform, and the teleradiology channel.

Ownership transitioned from Permira (2018-2026) to Hong Kong-based conglomerate Jardine Matheson in May 2026 in a deal valued at A$3.4 billion (US$2.4 billion), approximately 11.5x forecasted adjusted EBITDA and one of the first major transactions under Jardine's new CEO Lincoln Pan. Under Permira, the network expanded roughly threefold from ~70 to 215+ clinics. Leadership includes CEO Steven Rubic, CFO Clare Battellino, Head of Sales and Marketing Luke Targett, GM Operations Bruce Potts, and Chief Medical Officer Dr Ronald Shnier.

I-MED Network Radiology firmographics

Firmographics
Name
I-MED Network Radiology
Legal name
I-MED Radiology Network
Website
https://i-med.com.au
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
I-MED Radiology Network is Australia's largest diagnostic imaging provider, operating 215+ clinics across Australia, New Zealand, and the US, performing 7 million+ MRI, CT, X-ray, ultrasound, and PET procedures annually for patients, GPs, specialists, and hospitals under a Medicare mixed-billing and hospital outsourcing model.
Ownership category
akta.pro rank

I-MED Network Radiology industry classification

Industry
Product category
Diagnostic Imaging Services
NAICS
Diagnostic Imaging Centers (621512), Ambulatory Health Care Services (621)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
akta.pro primary industry
Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound) (HLAFAKAA)
akta.pro secondary industries
Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB), Nuclear Medicine & Molecular Imaging (SPECT/PET) (HLAHABAE), Women’s Imaging & Breast Health Centers (HLAFAJAJ), Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web) (HLACALAI)

Keywords

  • Diagnostic imaging services
  • Medical imaging network
  • Radiology clinics
  • Teleradiology services
  • Hospital outsourcing

Where I-MED Network Radiology is headquartered

Location

Headquarters

HQ city
Sydney
HQ country
Australia
HQ region
Oceania

Offices4 records

Markets served

I-MED Network Radiology business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Diagnostic Imaging Services: Fee-for-service medical imaging procedures where patients pay for radiology services. The company uses a mixed-billing policy combining Medicare rebates (processed by clinic on patient's behalf) plus provider gap fees. Services are provided across MRI, CT, X-ray, ultrasound, nuclear medicine, PET, mammography and interventional procedures.
  2. Hospital Outsourcing Contracts: I-MED serves as trusted outsourced provider to some of Australia's leading hospitals, delivering complex cardiac and diagnostic imaging services

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goStandard radiology procedures with Medicare rebate
SubscriptionPay-as-you-goNational Lung Cancer Screening Program (NLCSP)

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

I-MED Network Radiology product offering

Product offering

Core offering

I-MED Radiology Network operates Australia's largest diagnostic imaging network with 215+ clinics across Australia and New Zealand, providing MRI, CT, X-ray, ultrasound, nuclear medicine, PET scans, mammography, and interventional radiology procedures. Services are delivered to patients referred by GPs and specialists and through outsourced diagnostic imaging contracts with leading Australian hospitals.

Product overview

I-MED Radiology Network operates as Australia and New Zealand's largest diagnostic imaging network, offering a comprehensive range of medical imaging services across multiple modalities. The core offering is the I-MED clinic network providing MRI, CT, X-ray, ultrasound, nuclear medicine, PET scans, mammography, and interventional procedures. The network is complemented by patient-facing services including the My I-MED portal for appointment management and image access, and I-TeleRAD for teleradiology services. The organization has also integrated third-party clinical support technologies including Volpara Health's AI-based breast density measurement software and Qaelum DOSE radiation monitoring across its imaging systems.

Differentiator

Problem solved

Functional benefit

Brands

  • I-TeleRAD: Teleradiology services offered by I-MED for remote radiology reporting and image analysis.
  • My I-MED

Products and services

  • I-MED Radiology Network Diagnostic Imaging Services Comprehensive diagnostic imaging services across multiple modalities (MRI, CT, X-ray, ultrasound, nuclear medicine, PET scans, mammography, interventional procedures) provided through a network of 215+ clinics in Australia and New Zealand to patients referred by GPs and specialists.
  • Breast Tomosynthesis (3D Mammography) Advanced 3D mammography service available at select I-MED clinics that improves invasive breast cancer detection by 40% versus traditional mammography, using Volpara Health AI-based breast density measurement software to tailor examinations.
  • Cardiac Imaging Services Specialized cardiac imaging services delivered by 154+ accredited cardiac imaging radiologists, serving both hospital outsourcing clients and direct patient referrals.
  • National Lung Cancer Screening Program (NLCSP) Government-funded lung cancer screening service providing bulk-billed low-dose CT scans at no cost to eligible patients (aged 50-70 with 30+ pack-year smoking history) under the National Lung Cancer Screening Program effective from 1 July 2025.
  • I-TeleRAD Teleradiology Services Remote radiology reporting and image interpretation service offered under the I-TeleRAD brand, enabling diagnostic image analysis to be performed remotely for hospitals and healthcare facilities.
  • Hospital Outsourcing Services Outsourced radiology services delivered to leading Australian hospitals, including complex cardiac imaging and diagnostic procedures, serving public and private hospitals requiring supplementary radiology capacity and sub-specialist expertise.

Companies that use I-MED Network Radiology

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles2 records

I-MED Network Radiology technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature7 records

I-MED Network Radiology partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Harrison.aicoreTechnology or Integration · 25 May 2026I-MED holds a minority stake in Australian AI firm Harrison.ai, which develops radiology AI solutions including software capable of analyzing chest X-rays and CT scans across 455 diagnoses. Harrison.ai's technology is used by 3,400 clinicians across 1,000+ hospitals in more than 40 countries, providing I-MED with access to AI-powered diagnostic capabilities.
  • Jones RadiologyminorOthers · 25 September 2025Radiologists bought back control of Jones Radiology by acquiring the 49% stake previously held by I-Med Radiology Network. Jones Radiology had been part of I-Med for over 25 years before the buyback.
  • Radiology PartnersminorOthers · 1 January 2025Radiology Partners, America's largest radiology group, reportedly explored a bid to acquire I-MED from Permira, demonstrating market interest in I-MED's assets, though no transaction occurred.
  • StatRadcoreStrategic or Co-development Partner · 1 January 2024I-MED expanded into the US market through the 2024 acquisition of StatRad, a US-based radiology company. This represents I-MED's strategic entry into the American diagnostic imaging market.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

I-MED Network Radiology competitors and assessment

Company assessment

Broad incumbents

  • Radiology Partners: America's largest radiology group with a similar hospital-outsourcing and multi-site imaging model. Comparable in scale, multi-modality offering, and PE-backed growth playbook; explored acquiring I-MED from Permira in 2025, demonstrating direct strategic comparability.
  • Sonic Healthcare: ASX-listed diagnostics powerhouse providing pathology and radiology across Australia and globally. Overlaps with I-MED in Australian diagnostic imaging and shares a multi-modality, hospital-referral-driven business model.
  • Envision Healthcare: Large US physician and radiology services group. Broader healthcare services incumbent with overlapping radiology outsourcing but a much wider portfolio than I-MED's imaging-only focus.

Direct peers

  • Integral Diagnostics: ASX-listed radiology operator across Australia and New Zealand. Most direct geographic and operating-model peer to I-MED's ANZ clinic network, competing in many of the same metropolitan and regional markets.
  • Qscan Group: Private Australian radiology provider with a clinic network across multiple states. Directly comparable to I-MED in service mix, sub-specialist model, and hospital outsourcing contracts.
  • Healius Limited: Australian diagnostics operator (formerly Primary Health Care) running imaging and pathology assets. Directly comparable as a multi-site Australian imaging competitor with similar GP/specialist referral dynamics.
  • Capitol Health Limited: Australian diagnostic imaging group operating community-based clinics. Comparable mid-scale ANZ radiology competitor with overlapping modalities and referral channels.

Others

  • Volpara Health Technologies: NZ-based AI breast density software provider whose product is integrated into I-MED's mammography workflow. Adjacent technology supplier rather than direct competitor, but an important ecosystem participant for I-MED's women's imaging offering.
  • Harrison.ai: Australian AI company in which I-MED holds a minority stake. Comparable as a partner/investee rather than competitor — its radiology AI capabilities are deployed across I-MED's network.

Regional players

  • Akumin Inc. US-focused outpatient imaging and radiology services platform. Comparable in multi-site fixed-site imaging model but geographically distinct from I-MED's ANZ core footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

I-MED Network Radiology social profiles

Digital presence

I-MED Network Radiology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

I-MED Network Radiology leadership team

Management profile

Number of profiles

Profiles5 records

I-MED Network Radiology subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

I-MED Network Radiology funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

I-MED Network Radiology M&A and investment

M&A and investment

M&A3 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about I-MED Network Radiology

What does I-MED Network Radiology do?

I-MED Radiology Network operates Australia's largest diagnostic imaging network with 215+ clinics across Australia and New Zealand, providing MRI, CT, X-ray, ultrasound, nuclear medicine, PET scans, mammography, and interventional radiology procedures. Services are delivered to patients referred by GPs and specialists and through outsourced diagnostic imaging contracts with leading Australian hospitals.

Is I-MED Network Radiology a public or private company?

I-MED Network Radiology is a private company. It is classified as corporate owned and is currently operating.

When was I-MED Network Radiology founded?

I-MED Network Radiology was founded in 2000. It employs 1,001 to 5,000 people.

Where is I-MED Network Radiology based?

I-MED Network Radiology is headquartered in Sydney, Australia, in the Oceania region.

How does I-MED Network Radiology make money?

Two revenue lines are on record. Diagnostic Imaging Services are the primary driver. The others are hospital Outsourcing Contracts.

Who are I-MED Network Radiology's main competitors?

Broad incumbents on record are Radiology Partners, Sonic Healthcare and Envision Healthcare. Direct peers are Integral Diagnostics, Qscan Group, Healius Limited and Capitol Health Limited. Others are Volpara Health Technologies and Harrison.ai. Akumin Inc. is listed as a regional player.

Does I-MED Network Radiology have an API?

No public API is recorded for I-MED Network Radiology.

What industry is I-MED Network Radiology in?

I-MED Network Radiology's product category is Diagnostic Imaging Services. Its primary akta.pro industry code is HLAFAKAA, Radiology Imaging Centers (X-ray/CT/MRI/Ultrasound), with a secondary code of HLAFAKAB, Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology). Its NAICS code is 621512 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireTeleradiology Market Set to Reach USD 66.7 Billion by 2036, Expanding at 18.3% CAGR Amid Rising Demand for Remote Diagnostic Imaging | Future Market InsightsThe global teleradiology market is projected to grow from USD 10.5 billion in 2025 to USD 66.7 billion by 2036, an 18.3% CAGR. Growth is driven by radiologist shortages and rising imaging demand, with real-time reporting expected to hold 58% of service share in 2026.The Business TimesJardines has survived wars and market collapses. Can it survive the digital age?Jardine Matheson is undergoing a major strategic overhaul, shifting from an owner-operator model to a return-focused investment company, with at least US$10.5 billion in asset sales proposed or completed over the past year, including KFC and Pizza Hut chains, properties, and car dealerships. The conglomerate is pivoting toward developed Asia-Pacific markets like Australia and Japan, exemplified by its A$3.4 billion acquisition of I-MED Radiology Network from Permira, which includes a minority stake in AI firm Harrison.ai. Despite these proactive moves, the company's stock has underperformed, falling 5.4 percent year-to-date while the Straits Times Index gained 10.5 percent, with shares trading at a 34 percent discount to book value as investors remain skeptical of the transformation execution.Law.asiaFirms act on Jardine Matheson’s AUD3.4bn purchase of I-MEDJardine Matheson agreed to acquire 100% of Australian diagnostic imaging provider I-MED Radiology Network for AUD3.4 billion from Permira and other shareholders. The deal, expected to close in late 2026, includes I-MED's minority stake in Harrison.ai, a medical radiology AI company. I-MED operates 215 clinics across Australia and New Zealand, performing over 7 million procedures annually.The Business TimesSGX-listed Jardine Matheson eyes more Asia deals after US$10 billion spree to revamp empireJardine Matheson Holdings (JMH), a major Hong Kong-based conglomerate with listings in London and Singapore, is considering additional asset sales as part of a transformation strategy to become an investment-focused firm, having already completed or proposed approximately US$10.5 billion in asset sales and acquisitions over the past year. The company announced a US$2.4 billion acquisition of Australia's I-MED Radiology Network while shedding capital-intensive assets including Hong Kong property worth at least US$1.8 billion, restaurant chains (KFC and Pizza Hut), and car dealerships. JMH is pivoting toward developed Asia-Pacific markets like Australia and Japan to reduce its exposure to Southeast Asian geopolitical risks, with investors responding positively as the company's Singapore-listed shares have climbed more than 40 percent in the past year.Radiology BusinessPrivate equity firm selling radiology network for $2.4BPrivate equity firm Permira announced the sale of I-Med Radiology Network, Australia’s largest radiology provider, to Hong Kong-based conglomerate Jardine Matheson for $2.4 billion. I-Med operates 215 diagnostic imaging centers across Australia and New Zealand, handles approximately 7 million procedures annually, and recently expanded into the U.S. through the 2024 acquisition of StatRad; the deal represents a nearly 39% return for Permira, which originally acquired I-Med in 2018 for nearly $900 million. The transaction, expected to close by end of 2026 pending regulatory approval, includes a minority stake in Australian AI firm Harrison.ai and values I-Med at approximately 11.5x forecasted adjusted EBITDA, with Jardine planning to fund through a combination of existing cash and debt.Medical Device NetworkJardine Matheson to acquire I-MED Radiology Network for $2.4bnJardine Matheson agreed to acquire I-MED Radiology Network for A$3.4bn ($2.4bn), including its stake in Harrison.ai. The deal covers 100% of I-MED, which operates 215 clinics across Australia and New Zealand, with completion expected later in 2026.In VivoJardine Matheson Acquires Australia’s I-MED Radiology In $2.4Bn DealHong Kong conglomerate Jardine Matheson Holdings has agreed to acquire Australia's largest diagnostic imaging operator, I-MED Radiology Network, for AUD3.4bn ($2.4bn). The deal also grants Jardine a minority stake in radiology AI developer Harrison.ai, marking the group's entry into healthcare diagnostics for the first time. The acquisition signals further consolidation of Australia's diagnostic imaging market, where I-MED operates 215 clinics across Australia and New Zealand, performing more than seven million procedures annually.Pulse 2.0Jardine Matheson: AUS$3.4 Billion Acquisition Of I-MED Radiology Network From PermiraPermira Funds has agreed to sell I-MED Radiology Network to Jardine Matheson for an enterprise value of AUS$3.4 billion. I-MED is Australia's largest diagnostic imaging services provider, operating 215 clinics across Australia and New Zealand, performing more than seven million patient procedures annually. The transaction represents a significant exit for Permira, which acquired I-MED in 2018 and supported its expansion into new markets and AI-driven diagnostic capabilities.FinimizeJardine Matheson Bets On Medical Imaging With A$3.4 Billion I-MED DealJardine Matheson, a Hong Kong-based conglomerate, has agreed to acquire Australia's I-MED Radiology Network for an enterprise value of A$3.4 billion, financed through a mix of cash and debt. I-MED operates approximately 215 diagnostic imaging clinics across Australia and New Zealand and also runs teleradiology services, with the deal expected to close in late 2026 pending regulatory approval. The acquisition is expected to be neutral to earnings per share in the first full year after closing, then add to earnings thereafter, with the key test being whether I-MED can generate sufficient cash flow to outpace Jardine's funding costs.Investing.comJardine Matheson to buy Australia’s I-MED in $2.4 bln deal By Investing.comJardine Matheson announced its intent to acquire Australia's I-MED Radiology Network from Permira and other shareholders in a $2.4 billion deal, which will give it full ownership of the diagnostic imaging provider. The purchase includes I-MED’s stake in AI imaging firm Harrison.ai, and the deal is subject to regulatory approval, expected to close later in 2026.